- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PSS begins sales of BreastAlert
Equipment distributor Physician Sales & Service of Jacksonville, FL, has begun selling BreastAlert Differential Temperature Sensor, a device that assists in the early detection of breast cancer by discerning differences in temperature between breast
Equipment distributor Physician Sales & Service of Jacksonville, FL, has begun selling BreastAlert Differential Temperature Sensor, a device that assists in the early detection of breast cancer by discerning differences in temperature between breast tissue. HumaScan, the company with marketing rights to BreastAlert, began shipping the first BreastAlert sensors to PSS distribution facilities in late December. BreastAlert was developed by Scantek Medical of Denville, NJ, which granted U.S. and Canadian rights to the product to HumaScan of Cranford, NJ.
The device consists of heat-sensitive pads that are placed on each breast to measure breast tissue temperature, which can be higher in cancerous tissue due to the metabolic activity of early-stage tumors, HumaScan claims. A difference of 2F between mirror-image segments of the breasts indicates that pathology may be present and that a patient should be sent on for mammography screening. HumaScan hopes the product will prove useful in women under age 40, a population that is not recommended for mammography screening.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
